← Evidence map

ReviewCold Spring Harbor molecular case studies2017

ALK: a tyrosine kinase target for cancer therapy.

Vijaykumar R Holla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

92 papers cite itlatest 60 shown

2017
…
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28050598